Mazdutide
A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
Innovent · Phase 3 · Active, not recruiting · Enrollment 479
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Semaglutide | Obesity or overweight | n/r | 4 | n/r | n/r |
| IBI362 | Obesity or overweight | n/r | 4 | n/r | n/r |